0.4178 -0.00 (-0.02%)
After hours: 6:14PM EDT
| Previous Close | 0.4497 |
| Open | 0.4341 |
| Bid | 0.4100 x 1000 |
| Ask | 0.5000 x 2900 |
| Day's Range | 0.4104 - 0.4598 |
| 52 Week Range | 0.3500 - 4.9500 |
| Volume | 1,121,619 |
| Avg. Volume | 2,517,829 |
| Market Cap | 44.524M |
| Beta (3Y Monthly) | 0.99 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2650 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.00 |
LOS ANGELES, CA / ACCESSWIRE / October 18, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between December 14, 2017 and August 7, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before October 24, 2018.
NEW YORK, Oct. 18, 2018 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
NEW YORK, NY / ACCESSWIRE / October 17, 2018 / Pomerantz LLP announces that a class action lawsuit has been filedagainst Ampio Pharmaceuticals, Inc. (''Ampio'' or the ''Company'') (AMPE) and certain of its officers. The class action, filed in United States District Court, District of Colorado, and index under 18-cv-02252, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired the publicly traded securities of Ampio between December 14, 2017 and August 7, 2018, both dates inclusive (the ''Class Period''). Plaintiff seeks to recover compensable damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder.
NEW YORK, Oct. 17, 2018 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
LOS ANGELES, CA / ACCESSWIRE / October 17, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between December 14, 2017 and August 7, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before October 24, 2018.
NEW YORK, NY / ACCESSWIRE / October 17, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Ampio stock oroptions between December 14, 2017 and August 7, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/AMPE. You can also contact us by calling Richard Gonnello toll free at877-247-4292 or at 212-983-9330 or by sending an e-mail torgonnello@faruqilaw.com.
NEW YORK, Oct. 17, 2018 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
NEW YORK, Oct. 16, 2018 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Ampio Pharmaceuticals,.
LOS ANGELES, CA / ACCESSWIRE / October 16, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between December 14, 2017 and August 7, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before October 24, 2018.
NEW YORK, Oct. 16, 2018 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (AMPE) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Ampio securities between December 14, 2017 through August 7, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/ampe. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
LOS ANGELES, CA / ACCESSWIRE / October 15, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between December 14, 2017 and August 7, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before October 24, 2018.
NEW YORK, Oct. 14, 2018 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
If you are a shareholder who purchased Ampio securities between December 14, 2017, and August 7, 2018, both dates inclusive, you have until October 24, 2018, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980.
NEW YORK, NY / ACCESSWIRE / October 12, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE: ...
NEW YORK, Oct. 12, 2018 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Ampio Pharmaceuticals, Inc. (“Ampio” or the Company”) (NYSE: AMPE) in the United States District Court for the District of Colorado, on behalf of a class consisting of all persons who purchased or otherwise acquired the publicly traded securities of Ampio between December 14, 2017 and August 7, 2018, both dates inclusive (the “Class Period”). The filed Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
NEW YORK, Oct. 11, 2018 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
NEW YORK, NY / ACCESSWIRE / October 10, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Ampio Pharmaceuticals, Inc. (''Ampio'' or the ''Company'') (NYSE: AMPE) and certain ...
NEW YORK, Oct. 10, 2018 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of CV Sciences, Inc.,.
NEW YORK, Oct. 10, 2018 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
LOS ANGELES, CA / ACCESSWIRE / October 10, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between December 14, 2017 and August 7, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before October 24, 2018.
NEW YORK, Oct. 10, 2018 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Ampio.
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Ampio stock or options between December 14, 2017 and August 7, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/AMPE. The case, Jun Shi v. Ampio Pharmaceuticals, Inc. et al., No. 18-cv-07476 was filed on August 25, 2018 and has been assigned to Judge S. James Otero.
NEW YORK, Oct. 09, 2018 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.